Micro Market Research
+1-888-502-0539
US/CAN Toll Free

You are here :   Home     Healthcare     infertility Treatment     Global Drug Delivery Devices Market    
Real Time Market Research & Industry Analysis - MicroMarketMonitor

Global Pulmonary drug delivery devices Market Research Report

  • Report Code: RE 1000
  • Publish Date: Upcoming
  
Description
Table of Contents
Customer Intelligence
Summary
Inquiry Before Buying Ask for Discount

The global pulmonary drug delivery devices market is mainly driven by patent cliffs, increased incidence of chronic diseases, increasing competition, improving patient compliance, reformulation and repositioning of drugs using advanced oral delivery systems, and huge investments made by big pharmaceutical companies on in-house capabilities-for the development of oral drug delivery technologies. It was valued at $27.10 billion in 2013, and expected to grow at a CAGR of 12.20% to reach $48.20 billion by 2018.

 

The report ‘Global Pulmonary Drug Delivery devices Market forecast, 2012-2018’ analyzes the market by three segments, namely nebulizers, dry powder inhalers (DPIs), and metered dose inhalers (MDIs).

 

A significant trend in the usage of pulmonary devices is a shift from the traditionally used nebulizers to pressurized MDIs (pMDIs), and in the recent years, from pMDIs to DPIs. While pMDIs retain their position with the largest market size, DPIs are expected to overtake the market share of pMDIs. The market has also become more patient-centric with patient-friendly features such as dose counters and devices requiring low inspiratory efforts. Application of pulmonary delivery for non-respiratory therapies is expected to be a huge opportunity in this market.

 

The North American market segmentation in this report comprises of the United States and Canada. The key drivers for the pulmonary drug delivery devices market in North America are the robust pharmaceutical industry, large number of pharmaceutical companies and drug delivery technology providers, and the increasing number of collaborations and partnerships between technology providers and pharmaceutical companies. In addition, an increased demand for self-administration & home healthcare devices and increasing applications of inhalers, transdermal patches, and transmucosal systems for chronic disease areas such as migraine, diabetes, cancer pain, and asthma have boosted the growth of this market.

 

Europe holds the second position, in terms of value, in the overall pharmaceutical market. Europe accounts for five major European countries-Germany, France, the U.K., Italy, and Spain.

 

The major factors propelling the Asian market are the saturated western markets and economic slowdown in the U.S. and Europe. Furthermore, expansion of the Asian economy, increase in the disposable income, development of healthcare infrastructure, increasing penetration of health insurance, and rising prevalence of chronic diseases will drive the growth of the pharmaceutical market. This, in turn, will accelerate the growth of the pulmonary drug delivery market in Asia.

 

The report also provides an extensive competitive landscaping of companies operating in the pulmonary drug delivery market. The main companies operating in the market are GlaxoSmithKline Pharmaceuticals Limited (GSK), Boehringer Ingelheim GmbH, and Astra Zeneca.

 

Segment and country-specific company shares, news & deals, M&A, segment-specific pipeline products, product approvals, and product recalls of the major companies have been detailed in this report.

 

Customization Options

Along with the market data, you can also customize the MMM assessments that meet your company’s specific needs. Customize to get comprehensive industry standard and deep-dive analysis of the following parameters:

 

Product Analysis

  • Usage pattern (in-depth trend analysis) of products (segment-wise)
  • Product matrix which gives a detailed comparison of the product portfolio of each company, mapped at country and sub-segment level
  • End-user Adoption rate analysis of the products (segment-wise and country-wise)
  • Comprehensive coverage of product approvals, pipeline products, and product recalls

 

Pharmacists Forum

  • Fast turn-around analysis of pharmacists’ response to market events and trends
  • Pharmacists’ opinion about pulmonary drug delivery products from different companies
  • Pharmacists’ qualitative inputs on epidemiology data
  • Pattern analysis of usage of drugs by physicians

 

Brand/Product Perception Matrix

  • Comprehensive study of customers perception and behavior through our in-built social connect tool checking the virality and tonality of blogs
  • Analysis of overall brand usage and familiarity and brand advocacy distribution (detractor/neutral/familiar)


1 Introduction
1.1 Analyst Insights
1.2 Market Definitions
1.3 Market Segmentation & Aspects Covered
1.4 Research Methodology
2 Executive Summary
3 Market Overview
4 By Submarkets
4.1 Inhalers
5 By Technologies
5.1 Smart Pill Technology (SPT)
5.2 Microfluidics
6 By Groups
6.1 Pharmaceutical Packaging

Please fill in the form below to receive a free copy of the Summary of this Report
















Global Pulmonary drug delivery devices Market Research Report

* Enter the text from the image to the text box :

refresh captcha
Custom Market Research Services
We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit http://www.micromarketmonitor.com/custom-research-services.html to specify your custom Research Requirement
PRODUCT TITLE PUBLISHED
Metered Dose Inhalers Metered Dose Inhalers
Metered Dose Inhalers and Dry Powder Inhalers (DPI), Inhaler...
Upcoming
Dry Powder Inhalers (DPI) Dry Powder Inhalers (DPI)
Dry Powder Inhalers (DPI) and Metered Dose Inhalers, Inhaler...
Upcoming
Inhaler Nozzles Inhaler Nozzles
Inhaler Nozzles and Metered Dose Inhalers, Dry Powder...
Upcoming
Prefilled Inhalers Prefilled Inhalers
Prefilled Inhalers and Metered Dose Inhalers, Dry Powder...
Upcoming
North American Pulmonary drug delivery devices Market North American Pulmonary drug delivery devices Market
The North American Pulmonary Drug Delivery devices Market is mainly driven by patent cliffs and increased incidence of chronic diseases, increasing competition and improving patient compliance,huge investment made by big pharmaceutical companies.The Market was Valued at $13.8 billion in 2013 and expected to be $24 billion by 2018, growing at a CAGR of 11.8%. The Pulmonary Drug Delivery devices Market analyzes the market by segments such as nebulizers, dry powder inhalers (DPIs), and metered dose inhalers (MDIs).The prominent players in the Market are GlaxoSmithKline Pharmaceuticals Limited (GSK), Boehringer Ingelheim GmbH, and Astra Zeneca.
Upcoming
European Pulmonary drug delivery devices Market European Pulmonary drug delivery devices Market
The European Pulmonary Drug Delivery devices devices Market is mainly driven by patent cliffs and increased incidence of chronic diseases, increasing competition and improving patient compliance,huge investment made by big pharmaceutical companies.The Market was Valued at $7.5 billion in 2013 and expected to be $12.4billion by 2018, growing at a CAGR of 10.6%. The Pulmonary Drug Delivery devices Market analyzes the market by segments such as nebulizers, dry powder inhalers (DPIs), and metered dose inhalers (MDIs).The prominent players in the Market are GlaxoSmithKline Pharmaceuticals Limited (GSK), Boehringer Ingelheim GmbH, and Astra Zeneca.
Upcoming
Asian Pulmonary Drug Delivery devices Market Asian Pulmonary Drug Delivery devices Market
The Asian Pulmonary Drug Delivery devices Market is mainly driven by patent cliffs and increased incidence of chronic diseases, increasing competition and improving patient compliance,huge investment made by big pharmaceutical companies.The Market was Valued at $3.6 billion in 2013 and expected to be $7.7 billion by 2018, growing at a CAGR of 16.2%. The Pulmonary Drug Delivery devices Market analyzes the market by segments such as nebulizers, dry powder inhalers (DPIs), and metered dose inhalers (MDIs).The prominent players in the Market are GlaxoSmithKline Pharmaceuticals Limited (GSK), Boehringer Ingelheim GmbH, and Astra Zeneca.
Upcoming
7 of 7 items
7 reports | Show
Connect With Us
US/CAN : +1-888-502-0539